PIQ
PROTEOMICS INT LAB ORDINARYProteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and Southeast Asia. It provides PromarkerD, a blood test to predict diabetic kidney disease (DKD). The company's products under development include PromarkerEndo, which has completed clinical validation phase for endometriosis diagnosis; PromarkerEso, which has completed clinical validation trials for esophageal cancer diagnosis; and OxiDx (2-tag), which has completed clinical validation phase for oxidative stress treatment. It is also developing diagnostic tests for that includes DKD - T1D, that is under clinical phase for type 1 diabetes, diabetic retinopathy, and diabetic neuropathy; Asthma and COPD, which has completed proof-of-concept study trials for asthma and chronic obstructive pulmonary disease; Plant Dieback, that is under development phase for phytophthora dieback; Diabetic Retinopathy, which has completed discovery phase for sight-threatening retinopathy; and Diabetic Neuropathy, that is under research phase to investigate predictive biomarkers for diabetic neuropathy. The company also offers analytical services, such as specialist contract research focusing on biomarker discovery, biosimilars quality control, and pharmacokinetic testing for clinical trials. It has strategic collaboration with Harry Perkins Institute of Medical Research, Bioplatforms Australia, The University of Western Australia, Australian Research Council Training Centre, and the Australian Centre. Proteomics International Laboratories Ltd was founded in 2001 and is based in Nedlands, Australia.
PIQ
PIQ
PROTEOMICS INT LAB ORDINARY
Proteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and Southeast Asia. It provides PromarkerD, a blood test to predict diabetic kidney disease (DKD).
Fundamentals
Historical Data63 days
| Date | Short % | Gross Short |
|---|---|---|
| 16 July | — | — |
| 15 July | — | — |
| 14 July | — | — |
| 13 July | 0.57% | — |
| 10 July | 0.53% | — |
| 9 July | 0.47% | — |
| 8 July | 0.44% | — |
| 7 July | 0.39% | — |
| 6 July | 0.39% | — |
| 3 July | 0.36% | — |
| 2 July | 0.27% | — |
| 1 July | 0.25% | — |
Proteomics Int Lab (PIQ) Short Interest Summary
Proteomics Int Lab (PIQ) currently has 0.57% of its shares sold short (950 thousand shares, worth approximately $176K), based on ASIC short position data reported on 13 July 2026 (T+4 reporting lag). That makes PIQ the #301 most shorted stock on the ASX most shorted list. Short interest in PIQ is up 0.18% over the past week and up 0.16% over the past month. PIQ is part of the Health Care sector on the ASX.
Recent PIQ Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 13 July 2026 | 0.57% | 1.0M | $0.19 |
| 10 July 2026 | 0.53% | 0.9M | $0.20 |
| 9 July 2026 | 0.47% | 0.8M | $0.17 |
| 8 July 2026 | 0.44% | 0.7M | $0.16 |
| 7 July 2026 | 0.39% | 0.6M | $0.16 |
| 6 July 2026 | 0.39% | 0.6M | $0.17 |
| 3 July 2026 | 0.36% | 0.6M | $0.20 |
| 2 July 2026 | 0.27% | 0.4M | $0.16 |
| 1 July 2026 | 0.25% | 0.4M | $0.14 |
| 30 June 2026 | 0.26% | 0.4M | $0.12 |
PIQ Short Selling — Frequently Asked Questions
What is Proteomics Int Lab (PIQ)'s current short interest?
Proteomics Int Lab (PIQ) currently has a short interest of 0.57% of total shares outstanding. This means 0.57% of PIQ's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is PIQ heavily shorted on the ASX?
PIQ has a relatively low short interest of 0.57%. Short interest below 5% generally suggests limited bearish sentiment from short sellers.
What does short interest mean for PIQ investors?
Short interest in PIQ shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 0.57%, PIQ's short interest is at a low level. See our short squeeze candidates and days to cover analysis for more context.
Where does this PIQ short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for PIQ.